Nick Flinn is an experienced professional in the pharmaceutical sector, having served in various leadership roles. At Amura Therapeutics Ltd from January 2001 to May 2017, Nick established the DMPK screening program and validated multiple assays for compound libraries. Following this, Nick held several positions at Roche, progressing from Safety Scientist to Senior Director, Clinical Safety, focusing on safety strategy and clinical safety leadership from April 2018 to October 2019. Additionally, Nick was the Director at Aclardian Limited from July 2012 to November 2017, managing operations and business growth for a pharmaceutical wholesaler. In parallel, Nick served as Superintendent Pharmacist at Ascrip Pharmacy, overseeing clinical governance and securing NHS contracts to provide pharmaceutical care. Academically, Nick earned a Bachelor of Pharmacy and a Ph.D. in Medicinal and Pharmaceutical Chemistry from the School of Pharmacy, University of London.
This person is not in the org chart
This person is not in any teams
This person is not in any offices